Distinct regulation of plasma LDL cholesterol by eicosapentaenoic acid and docosahexaenoic acid in high fat diet-fed hamsters: participation of cholesterol ester transfer protein and LDL receptor

Prostaglandins Leukot Essent Fatty Acids. 2013 Apr;88(4):281-8. doi: 10.1016/j.plefa.2013.01.001. Epub 2013 Jan 30.

Abstract

Despite established anti-atherogenic action, previous reports have shown that fish oils or n-3 poly-unsaturated fatty acid (PUFA) increase plasma LDL-C in animals and humans. However, which component of n-3 PUFAs and what mechanisms contribute to this increase are unclear. We investigated the effects of the major components of n-3 PUFA, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on plasma LDL-C in high fat diet-fed hamsters. While LDL-C increased significantly with n-3 PUFA oil and DHA, EPA had no effect on LDL-C. Interestingly, a positive correlation was found between plasma cholesterol ester transfer protein (CETP) activity and LDL-C. Only DHA increased plasma CETP activity and significantly decreased LDL receptor expression in the liver. Our data suggest that DHA, not EPA, is a major factor in the LDL-C increasing effect of n-3 PUFA oil. These differential effects on LDL-C may arise from differences in plasma CETP activity and LDL receptor expression.

MeSH terms

  • Animals
  • Cholesterol Ester Transfer Proteins / metabolism*
  • Cholesterol, LDL / blood*
  • Cricetinae
  • Diet, High-Fat / adverse effects*
  • Docosahexaenoic Acids / pharmacology*
  • Eicosapentaenoic Acid / pharmacology*
  • Fatty Acids, Omega-3 / pharmacology
  • Receptors, LDL / metabolism*

Substances

  • Cholesterol Ester Transfer Proteins
  • Cholesterol, LDL
  • Fatty Acids, Omega-3
  • Receptors, LDL
  • Docosahexaenoic Acids
  • Eicosapentaenoic Acid